Vidarabine sodium phosphate

This classification denotes an antiviral agent with the molecular structure C10H12N5O7P.2NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, ZEC0WCC7UA chemically known as 9-.beta.-d-arabinofuranosyladenine 5'-(dihydrogen phosphate), disodium salt, but more commonly known as vidarabine sodium phosphate, which bears US NIH Compound Identifier 224. European Medicines Agency schedules Vidarabine sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05095MIG. Most nations, for tariff and trade purposes, schedule vidarabine sodium phosphate under HS 29349990 and SITC 51579. As of Q4 2014, VIDARABINE SODIUM PHOSPHATE remains US FDA's Preferred Term for this commodity. Vidarabine sodium phosphate bears US NLM identifiers UMLS ID C0771597 and NCI Concept Code C95911. SMILES: C1NC(C2C(N1)N(CN2)[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)N.[NA+].[NA+].